The immunotherapy breakthroughs in cervical cancer: Focus on potential biomarkers and further therapy advances

The immunotherapy breakthroughs in cervical cancer: Focus on potential biomarkers and further therapy advances

Despite the well-established role of human papillomavirus (HPV) as the primary cause of cervical cancer (CC) and the existence of an effective HPV vaccine, over half a million women are diagnosed with CC globally each year, with more than half of them dying from the disease. Immunotherapy has rapidl...

Full description

Saved in:
Bibliographic Details
Main Authors: Maja Pezer Naletilić, Krešimir Tomić, Kristina Katić, Zoran Gatalica, Gordan Srkalović, Eduard Vrdoljak, Semir Vranić
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2025-05-01
Series:Biomolecules & Biomedicine
Subjects:
Cervical cancer
CC
immunotherapy
immune checkpoint inhibitors
ICIs
biomarkers
Online Access:https://www.bjbms.org/ojs/index.php/bjbms/article/view/12597
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items